In this Friday’s PCT Grand Rounds, Patrick Lawler of the McGill University Health Centre will present “The REMAP-CAP Adaptive Platform Trial: Recent Insights and Future Directions.”
The Grand Rounds session will be held on Friday, August 11, 2023, at 1:00 pm eastern.
The REMAP-CAP trial (Randomized, Embedded, Multifactorial, Adaptive Platform Trial for Community-Acquired Pneumonia) has a novel adaptive trial design to evaluate several treatment options simultaneously and efficiently. The design is able to adapt in the event of pandemics, and it increases the likelihood that patients will receive the treatment that is most likely to be effective for them.
REMAP-CAP was previously in the Rethinking Clinical Trials Grand Rounds spotlight on May 15, 2020, and April 2, 2021.
Lawler is a cardiologist and clinician-scientist at the McGill University Health Centre in Montreal and the Peter Munk Cardiac Centre at University Health Network in Toronto.